Paul W Jones
Overview
Explore the profile of Paul W Jones including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
211
Citations
9284
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Gicas K, Benitah K, Thornton A, Petersson A, Jones P, Stubbs J, et al.
Clin Neuropsychol
. 2023 Feb;
37(8):1710-1727.
PMID: 36790121
Homeless and precariously housed persons exhibit significant memory impairment, but the component processes underlying memory dysfunction have not been explored. We examined the serial position profile (i.e., primacy and recency...
12.
Shinoda M, Hataji O, Miura M, Kinoshita M, Mizoo A, Tobino K, et al.
Int J Chron Obstruct Pulmon Dis
. 2022 Nov;
17:2931-2944.
PMID: 36419950
Background: Telemedicine may help the detection of symptom worsening in patients with chronic obstructive pulmonary disease (COPD), potentially resulting in improved outcomes. This study aimed to determine the feasibility and...
13.
Halpin D, Kendall R, Shukla S, Martin A, Shah D, Midwinter D, et al.
Int J Chron Obstruct Pulmon Dis
. 2022 Nov;
17:2745-2755.
PMID: 36317185
Purpose: The 24-week INTREPID trial demonstrated the clinical benefits of once-daily single-inhaler triple therapy (SITT) with fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) versus non-ELLIPTA multiple-inhaler triple therapy (MITT) in patients...
14.
Yorke J, Khan N, Garrow A, Tyson S, Singh D, Vestbo J, et al.
Int J Chron Obstruct Pulmon Dis
. 2022 Sep;
17:2289-2299.
PMID: 36133735
Purpose: The modified-Medical Research Council (mMRC) breathlessness scale consists of five grades that contain of a description of different activities. It has wide utility in the assessment of disability due...
15.
Maltais F, Vogelmeier C, Kerwin E, Bjermer L, Jones P, Boucot I, et al.
Respir Med
. 2022 Jul;
200:106918.
PMID: 35803172
Early MAXimisation of bronchodilation for improving COPD stability (EMAX) was a large, multicentre, multi-national, randomised, double-blind, 24-week trial. EMAX evaluated the efficacy and safety of dual bronchodilator therapy with umeclidinium...
16.
Lu Y, Jones P, Caraballo C, Mahajan S, Massey D, Ahmed R, et al.
J Card Fail
. 2022 Jun;
28(8):1372-1374.
PMID: 35690314
No abstract available.
17.
Yi X, Li Y, Liu H, Liu X, Yang J, Gao J, et al.
Microbiol Spectr
. 2022 Mar;
10(2):e0259321.
PMID: 35311590
Antimicrobial resistance is a global concern in chronic respiratory diseases, including chronic obstructive pulmonary disease (COPD). The collection of antibiotic resistance genes or resistome in human airways may underlie the...
18.
Capucci A, Wong J, Gold M, Boehmer J, Ahmed R, Kwan B, et al.
JACC Clin Electrophysiol
. 2022 Feb;
8(2):182-193.
PMID: 35210075
Objectives: This study sought to investigate the temporal association between changes in physiologic heart failure (HF) sensors, atrial fibrillation (AF) progression, and clinical HF in patients with cardiac resynchronization therapy...
19.
Jones P, Wang C, Chen P, Chen L, Wang D, Xia J, et al.
Int J Chron Obstruct Pulmon Dis
. 2022 Jan;
17:213-222.
PMID: 35087270
Introduction: Many patients with chronic obstructive pulmonary disease (COPD) do not report exacerbations and may benefit from simple guidance about when to seek medical attention, so we developed a COPD...
20.
Lu Y, Jones P, Murugiah K, Caraballo C, Massey D, Mahajan S, et al.
J Am Coll Cardiol
. 2022 Jan;
79(3):309-310.
PMID: 35057917
No abstract available.